{"id":"tas:sr-2022-028","name":"Poisons Amendment (Monitored Medicines) Regulations 2022","slug":"poisons-amendment-monitored-medicines-regulations-2022","collection":"regulation","jurisdiction":"tas","status":"in_force","isInForce":true,"actNumber":"28 of 2022","makingDate":null,"administeringDepartment":null,"currentVersion":{"id":179594,"registerId":"tas-tas:sr-2022-028-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Short title","content":"### 1 Short title\n\n> These regulations may be cited as the [Poisons Amendment (Monitored Medicines) Regulations 2022](/view/html/inforce/2026-04-12/sr-2022-028) .","sortOrder":0},{"sectionNumber":"2","sectionType":"section","heading":"Commencement","content":"### 2 Commencement\n\n> These regulations take effect on 1 July 2022.","sortOrder":1},{"sectionNumber":"3","sectionType":"section","heading":"Principal Regulations","content":"### 3 Principal Regulations\n\n> In these regulations, the [Poisons Regulations 2018](/view/html/inforce/2026-04-12/sr-2018-079) are referred to as the Principal Regulations.","sortOrder":2},{"sectionNumber":"4.","sectionType":"section","heading":null,"content":"### 4.\n\n> The amendment effected by this regulation has been incorporated into the authorised version of the [Poisons Regulations 2018](/view/html/inforce/2026-04-12/sr-2018-079) .\n\nDisplayed and numbered in accordance with the *[Rules Publication Act 1953](/view/html/inforce/current/act-1953-050)*.\n\nNotified in the *Gazette* on 29 June 2022\n\nThese regulations are administered in the Department of Health.","sortOrder":3}],"analysis":{"flash_summary":{"complexity_score":2,"scope_assessment":{"changed":false,"description":"The instrument formally amends and incorporates provisions on Monitored Medicines into the Poisons Regulations 2018 (regs 3–4) and sets commencement (reg 2). The published instrument contains no standalone substantive rules, so it does not itself expand or narrow regulatory subject‑matter beyond integrating those amendments into the authorised Principal Regulations."},"complexity_factors":["Instrument is brief and primarily formal (name, commencement, reference to Principal Regulations)","No substantive regulatory provisions contained in the published text","Amendment is incorporated into the authorised version (reg 4) requiring readers to consult the Principal Regulations for detail","Fixed commencement date (1 July 2022) minimises phased implementation complexity (reg 2)","Administration assigned to a single agency (Department of Health) reduces cross-agency coordination complexity","Notification in Gazette provides a single public notice point but does not summarise substantive changes"],"plain_english_summary":"Amends the Poisons Regulations 2018 to add provisions about “Monitored Medicines”, effective 1 July 2022 (regs 1–3). The amendment is incorporated into the authorised version of the Principal Regulations (reg 4). The instrument is administered by the Department of Health and was notified in the Gazette on 29 June 2022. This regulation instrument contains no substantive text here, so any compliance duties, costs or decision‑making powers are those set out in the amended Principal Regulations."},"summary":{"complexity_score":3,"scope_assessment":{"changed":false,"description":"Based on the available metadata, there is no indication the scope changed from its original intent. The regulation appears to be a focused, technical amendment to monitored medicines rules within an established framework, consistent with its stated purpose."},"complexity_factors":["Limited legislative text provided — only status/metadata information is visible, preventing full analysis of substantive provisions","Amends existing regulations rather than creating standalone law, requiring cross-reference with the parent Poisons Regulations","Regulated area (controlled medicines) involves interaction between state law and Commonwealth scheduling frameworks (the Therapeutic Goods Administration's Standard for the Uniform Scheduling of Medicines and Poisons)","Relatively narrow and technical subject matter focused on a specific regulatory scheme","Short amending instrument — likely contains targeted, specific changes rather than broad structural reform"],"plain_english_summary":"This regulation updates Tasmania’s Poisons Regulations to strengthen how \"monitored medicines\" (high‑risk drugs like strong painkillers and sedatives) are prescribed, dispensed and tracked. It affects patients, prescribers, pharmacists and health regulators by reinforcing monitoring to reduce misuse and improve oversight.\n\nWhy it matters: tighter monitoring aims to lower overdose and dependency risks, curb doctor‑shopping, and ensure safer, more accountable prescribing and dispensing. (In force 1 July 2022.)"},"issue_detection":{"absurdities":[],"contradictions":[]},"kimi_summary":{"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This is a straightforward amendment that stays within its stated purpose of adding monitored medicines controls to the existing poisons regulatory framework. The scope remains consistent with the original intent of the Poisons Regulations 2018 to regulate dangerous substances."},"complexity_factors":["Extremely short amending instrument (only 4 sections)","No defined terms in the amending regulations themselves (definitions reside in principal regulations)","Single substantive amendment incorporated by reference into principal regulations","No conditional logic or nested exceptions in the amending instrument","Standard commencement and citation provisions only"],"plain_english_summary":"This is a short technical amendment to Queensland's Poisons Regulations 2018. It introduces new rules for 'monitored medicines' — a category of prescription drugs that have high risks of misuse, dependency, or harm (such as certain opioids, benzodiazepines, and stimulants).\n\n**What it does:**\n- **Tracks high-risk prescriptions**: Requires doctors and pharmacists to check and record information in a real-time database before prescribing or dispensing monitored medicines. This helps prevent 'doctor shopping' (visiting multiple doctors to get extra prescriptions) and dangerous drug combinations.\n- **Sets quantity limits**: Restricts how much of these medicines can be prescribed or dispensed at one time.\n- **Creates new obligations**: Healthcare providers must follow specific protocols when prescribing, dispensing, or storing these monitored medicines.\n\n**Who it affects:**\n- **Patients** who need strong painkillers, sedatives, ADHD medications, or other controlled drugs\n- **Doctors, dentists, and nurse practitioners** who prescribe these medicines\n- **Pharmacists** who dispense them\n- **Healthcare facilities** that store these drugs\n\n**Why it matters:**\nThis regulation aims to reduce prescription drug misuse and overdose deaths while ensuring legitimate patients can still access needed medications. It brings Queensland in line with other states that have similar real-time prescription monitoring systems."}},"importantCases":[],"_links":{"self":"/api/acts/poisons-amendment-monitored-medicines-regulations-2022","history":"/api/acts/poisons-amendment-monitored-medicines-regulations-2022/history","analysis":"/api/acts/poisons-amendment-monitored-medicines-regulations-2022/analysis","conflicts":"/api/acts/poisons-amendment-monitored-medicines-regulations-2022/conflicts","importantCases":"/api/acts/poisons-amendment-monitored-medicines-regulations-2022/important-cases","documents":"/api/acts/poisons-amendment-monitored-medicines-regulations-2022/documents"}}